Mech Sense
- Address
- Moelleparkvej 4, 9000 Aalborg, Denmark
Digestive System Research
At Mech Sense in Aalborg, the Department of Gastroenterology and Hepatology is running clinical research focused on Digestive System Diseases, with an emphasis on conditions that affect comfort, digestion, and quality of life.
- Research in chronic pancreatitis is exploring ways to reduce pain and improve physical function and daily well-being.
- Studies on opioid induced bowel dysfunction are examining how bowel activity and digestive movement are affected by opioid use.
- These trials aim to test new treatment approaches and better understand digestive symptoms using objective clinical assessment.
The site combines patient-centered work on symptom relief with research into how the gastrointestinal tract responds to treatment and medication.
Chronic Pancreatitis Studies
One key area of investigation at this research facility is chronic pancreatitis, where trials are focused on easing persistent pain and supporting better everyday functioning for affected patients.
- Exploring a potential new therapy for painful chronic pancreatitis.
- Assessing whether treatment can lower symptom burden and improve quality of life.
- Advancing care for a long-term digestive disease with significant impact on patients' lives.
This research reflects a broader effort to improve treatment options in gastroenterology through carefully designed clinical studies.
Opioid-Related Bowel Function Research
Another important focus is opioid induced bowel dysfunction, where studies are evaluating how medicines and opioids influence bowel transit, motility, secretion, and colon volume.
- Testing a treatment approach for opioid-related bowel dysfunction.
- Studying the digestive effects of tramadol in a controlled research setting.
- Improving understanding of how opioid use alters gastrointestinal performance.
These trials support better diagnosis and management of medication-related digestive problems in patients treated at Mech Sense.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Aalborg University Hospital1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Aalborg University Hospital3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Mech Sense
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Naldemedine on Opioid-Induced Bowel Dysfunction in Patients Receiving Tramadol: A Randomized, Double-Blind, Placebo-Controlled Trial | Aalborg University Hospital | Phase II | Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| NALDEMEDINE | 1 | Unknown | 2024-08-12 | 2024-08-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
